Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism
Authors:
- Y. TanakaYTY. Tanaka
- T. SatohTST. Satoh
- M. KawaiMKM. Kawai
- M. HirakataMHM. Hirakata
- J. KaburakiJKJ. Kaburaki
- Y. KawakamiYKY. Kawakami
- Y. IkedaYIY. Ikeda
- M. KuwanaMKM. Kuwana
Open Access
- 27 September 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 45 (2) , 150-156
Abstract
Objectives. To examine the prevalence, clinical associations and pathogenic roles of autoantibodies to CD40 ligand (CD40L) in patients with systemic lupus erythematosus (SLE). Methods. Plasma anti-CD40L antibodies from 125 patients with SLE, 24 with primary antiphospholipid syndrome (APS) and 90 with idiopathic thrombocytopenic purpura (ITP) and from 62 healthy individuals were measured with an enzyme-linked immunosorbent assay (ELISA). HeLa cells transfected with human CD40L cDNA (HeLa/CD40L) were used to confirm the presence of anti-CD40L autoantibodies. The effect of anti-CD40L antibodies on the CD40L-CD40 interaction was evaluated by observing CD40L-induced IκB activation in CD40-expressing fibroblasts. Results. Anti-CD40L autoantibody was detected in seven (6%) SLE, three (13%) primary APS and 11 (12%) ITP patients, but in no healthy controls. Antibody binding in an ELISA was competitively inhibited by membrane components of HeLa/CD40L. Anti-CD40L antibody-positive IgG specifically bound the surface of living HeLa/CD40L, as shown by flow cytometry. The frequency of thrombocytopenia was significantly higher in SLE patients with the anti-CD40L antibody than in those without (100 vs 14%; PConclusions. Anti-CD40L autoantibody is associated with thrombocytopenia but not thromboembolism. Our findings are potentially useful in understanding the complex roles of CD40L in the pathophysiology of thrombosis and haemostasis as well as the thromboembolic complications that occur during treatment with anti-CD40L humanized antibody.Keywords
This publication has 27 references indexed in Scilit:
- Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpuraBlood, 2003
- A short course of BG9588 (anti–CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritisArthritis & Rheumatism, 2003
- Biogen has stopped all trials involving anti-GP39 monoclonal antibodyReactions Weekly, 1999
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- Functions of CD40 and Its Ligand, gp39 (CD40L)Critical Reviews in Immunology, 1996
- Detection of Anti-DNA Topoisomerase I Antibody by an Enzyme-Linked Immunosorbent Assay Using Overlapping Recombinant PolypeptidesClinical Immunology and Immunopathology, 1995
- Defective Expression of CD40 Ligand on T Cells Causes “X‐Linked Immunodeficiency with Hyper‐IgM (HIGM1)”Immunological Reviews, 1994
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activationImmunology Today, 1992
- Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabeled cell extractsArthritis & Rheumatism, 1985